Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unveiling the variations in penile cancer care: identifying knowledge gaps and research priorities.

BMJ oncology·2026
Same author

High-throughput in situ sizing and quantum yield determination of individual perovskite nanocrystals.

Nature materials·2026
Same author

Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Pattern of resistance on first-line EGFR-directed therapy in EGFR-positive metastatic NSCLC.

Ecancermedicalscience·2026
Same author

Prognostic Factors in Oropharyngeal Cancer Treated With Definitive Chemoradiotherapy.

Cancer medicine·2026
Same author

Contemporary management of adrenocortical carcinoma: A narrative review.

Urologic oncology·2026
Same journal

Identification of chondroitin polymerizing factor as a biomarker for predicting immunotherapy response in breast cancer: a bioinformatics analysis of tumor microenvironment.

Translational cancer research·2026
Same journal

Neuro-glioma activity-dependent growth mechanisms: an actionable circuit from NLGN3-ADAM10 to AMPA synapses.

Translational cancer research·2026
Same journal

Association of serum vitamins and carotenoids with breast cancer status among adult women in NHANES 2017-2018: a cross-sectional study.

Translational cancer research·2026
Same journal

Development and validation of prognostic nomograms for patients with cervical cancer and liver metastasis: a SEER-based study.

Translational cancer research·2026
Same journal

Circadian-immune-related gene signature for lung squamous cell carcinoma: machine learning and multi-omics analysis.

Translational cancer research·2026
Same journal

Epidemiology and prognostic factors of acute erythroid leukemia.

Translational cancer research·2026
See all related articles

Related Experiment Video

Updated: Apr 29, 2026

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.2K

Externally modulated theranostic nanoparticles.

Cordula Urban1, Alexander S Urban2, Heather Charron1

  • 1Department of Radiology, Baylor College of Medicine, Houston, TX, USA.

Translational Cancer Research
|May 17, 2014
PubMed
Summary
This summary is machine-generated.

Externally modulated nanoparticles offer precise cancer treatment control. These theranostic agents combine targeted delivery with external field manipulation for enhanced efficacy and reduced side effects.

Keywords:
Cancer nanotechnologyNIR therapygold nanoparticles (AuNPs)hyperthermiatheranostics

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

2.7K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

867

Related Experiment Videos

Last Updated: Apr 29, 2026

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.2K
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

2.7K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

867

Area of Science:

  • Nanomedicine
  • Biotechnology
  • Oncology

Background:

  • Externally modulated nanoparticles represent an emerging class of cancer nanotherapeutics.
  • These agents combine passive tumor accumulation with external control over therapy delivery.
  • They offer potential for enhanced therapeutic efficacy and reduced off-target effects.

Purpose of the Study:

  • To classify externally modulated theranostic nanoparticles based on external control modes.
  • To describe the underlying physicochemical mechanisms of external control.
  • To illustrate nanoparticle embodiments with proven biological efficacy.

Main Methods:

  • Review and classification of nanoparticles based on external modulation (optical, magnetic, ultrasound).
  • Analysis of physiochemical mechanisms governing external control of therapy.
  • Illustration of specific nanoparticle systems and their biological applications.

Main Results:

  • Electromagnetic radiation (visible/near-infrared) utilizes gold/carbon nanostructures for imaging and photothermal therapy (PTT).
  • Magnetic field manipulation employs iron-oxide nanostructures for magnetic resonance imaging (MRI) and magnetothermal therapy.
  • Ultrasound methods primarily enhance the delivery of nanotherapeutics to tumor sites.

Conclusions:

  • Externally modulated theranostic nanoparticles offer precise spatio-temporal control over cancer therapy.
  • These agents provide theranostic capabilities, integrating diagnostics and therapeutics.
  • Diverse nanoparticle platforms are being developed for various external modulation strategies in cancer treatment.